• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Recognizing potential immune checkpoint inhibitor-associated optic neuritis: insights from the FDA adverse event reporting system.

作者信息

He Chang-Zhu, Qiu Qin, He Yu

机构信息

Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, Sichuan, China.

Department of Ophthalmology, Chengdu First People's Hospital/Chengdu Integrated TCM and Western Medicine Hospital, Chengdu, 610041, Sichuan, China.

出版信息

Int Ophthalmol. 2025 Aug 25;45(1):353. doi: 10.1007/s10792-025-03743-8.

DOI:10.1007/s10792-025-03743-8
PMID:40853404
Abstract
摘要

相似文献

1
Recognizing potential immune checkpoint inhibitor-associated optic neuritis: insights from the FDA adverse event reporting system.识别潜在的免疫检查点抑制剂相关视神经炎：来自美国食品药品监督管理局不良事件报告系统的见解
Int Ophthalmol. 2025 Aug 25;45(1):353. doi: 10.1007/s10792-025-03743-8.
2
Immune checkpoint inhibitor-associated myocarditis and pericarditis: a pharmacovigilance study based on the FAERS database.免疫检查点抑制剂相关的心肌炎和心包炎：一项基于FAERS数据库的药物警戒研究。
BMC Cancer. 2025 Aug 9;25(1):1294. doi: 10.1186/s12885-025-14668-x.
3
Adverse events associated with acute pancreatitis caused by immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database.
Expert Opin Drug Saf. 2025 Mar 29:1-9. doi: 10.1080/14740338.2025.2486311.
4
Adverse events associated with immune checkpoint inhibitors in non-small cell lung cancer: a safety analysis of clinical trials and FDA pharmacovigilance system.免疫检查点抑制剂在非小细胞肺癌中的不良反应：临床试验和 FDA 药物警戒系统的安全性分析。
Front Immunol. 2024 Apr 30;15:1396752. doi: 10.3389/fimmu.2024.1396752. eCollection 2024.
5
Gender and age disparities in cardiac immune-related adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FAERS database.免疫检查点抑制剂相关心脏免疫不良事件中的性别和年龄差异：FAERS数据库的药物警戒分析
BMJ Open. 2025 Jun 12;15(6):e090087. doi: 10.1136/bmjopen-2024-090087.
6
Immune checkpoint inhibitor-associated autoimmune encephalitis and other neurological immune-mediated adverse events: a pharmacovigilance study using the FAERS and JADER.免疫检查点抑制剂相关的自身免疫性脑炎及其他神经免疫介导的不良事件：一项使用美国食品药品监督管理局不良事件报告系统（FAERS）和日本药品不良反应报告数据库（JADER）的药物警戒研究
Front Oncol. 2025 Jul 17;15:1621045. doi: 10.3389/fonc.2025.1621045. eCollection 2025.
7
Post-marketing safety signals of imatinib: pharmacovigilance insights from the FDA Adverse Event Reporting System (FAERS) and implications for clinical practice.伊马替尼的上市后安全信号：来自美国食品药品监督管理局不良事件报告系统（FAERS）的药物警戒见解及其对临床实践的影响。
Eur J Clin Pharmacol. 2025 Jul 8. doi: 10.1007/s00228-025-03872-0.
8
Immune-related adverse events of immune checkpoint inhibitors combined with angiogenesis inhibitors: A real-world pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database (2014-2022).免疫检查点抑制剂联合血管生成抑制剂的免疫相关不良事件：FDA 不良事件报告系统（FAERS）数据库（2014-2022 年）的真实世界药物警戒分析。
Int Immunopharmacol. 2024 Jul 30;136:112301. doi: 10.1016/j.intimp.2024.112301. Epub 2024 Jun 4.
9
PD-1/PD-L1 inhibitor-induced hyponatremia: a real-world pharmacovigilance analysis using FAERS database.程序性死亡受体1/程序性死亡配体1抑制剂诱导的低钠血症：一项使用FDA不良事件报告系统数据库的真实世界药物警戒分析
Front Immunol. 2025 Jun 16;16:1561942. doi: 10.3389/fimmu.2025.1561942. eCollection 2025.
10
Cytokine release syndrome associated with immune checkpoint inhibitors: a pharmacovigilance study based on spontaneous reports in FAERS.与免疫检查点抑制剂相关的细胞因子释放综合征：一项基于FAERS自发报告的药物警戒研究。
Expert Opin Drug Saf. 2024 Jul 29:1-8. doi: 10.1080/14740338.2024.2385489.

本文引用的文献

1
Long-term surveillance of the anti-amyloid monoclonal antibody lecanemab: rights and duties of pharmacovigilance.抗淀粉样蛋白单克隆抗体lecanemab的长期监测：药物警戒的权利与义务
Alzheimers Res Ther. 2025 Apr 11;17(1):80. doi: 10.1186/s13195-025-01699-6.
2
Neuro-ophthalmic Complications of Immune Checkpoint Inhibitors: A Systematic Review.免疫检查点抑制剂的神经眼科并发症：一项系统综述
Eye Brain. 2020 Nov 3;12:139-167. doi: 10.2147/EB.S277760. eCollection 2020.
3
Ophthalmic adverse effects of immune checkpoint inhibitors: the Mayo Clinic experience.
免疫检查点抑制剂的眼部不良反应：梅奥诊所的经验。
Br J Ophthalmol. 2021 Sep;105(9):1263-1271. doi: 10.1136/bjophthalmol-2020-316970. Epub 2020 Aug 23.
4
Immune Checkpoint Inhibitor-Associated Optic Neuritis.免疫检查点抑制剂相关视神经炎。
Ophthalmology. 2020 Nov;127(11):1585-1589. doi: 10.1016/j.ophtha.2020.05.003. Epub 2020 May 8.
5
Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database.药物警戒数据库中用于识别药物不良反应的不成比例性分析的益处与优势。
Br J Clin Pharmacol. 2011 Dec;72(6):905-8. doi: 10.1111/j.1365-2125.2011.04037.x.